Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months
(Q63728608)
scientific article published on 01 February 2010
scientific article published on 01 February 2010
Language:
Current Data About
Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months
other details
| description | scientific article published on 01 February 2010 |
External Links
| (P356) |
10.1016/J.CGH.2010.01.014
|
| (P698) |
20117244
|